IL51853A - 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL51853A
IL51853A IL51853A IL5185377A IL51853A IL 51853 A IL51853 A IL 51853A IL 51853 A IL51853 A IL 51853A IL 5185377 A IL5185377 A IL 5185377A IL 51853 A IL51853 A IL 51853A
Authority
IL
Israel
Prior art keywords
indolo
hexahydro
tetrahydro
preparation
pharmaceutical compositions
Prior art date
Application number
IL51853A
Other languages
English (en)
Other versions
IL51853A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7610773A external-priority patent/FR2358146A1/fr
Priority claimed from FR7616445A external-priority patent/FR2353550A2/fr
Priority claimed from FR7632319A external-priority patent/FR2368955A2/fr
Priority claimed from FR7639035A external-priority patent/FR2374905A2/fr
Priority claimed from FR7707249A external-priority patent/FR2383182A2/fr
Priority claimed from FR7707248A external-priority patent/FR2383181A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL51853A0 publication Critical patent/IL51853A0/xx
Publication of IL51853A publication Critical patent/IL51853A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL51853A 1976-04-13 1977-04-11 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them IL51853A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR7610773A FR2358146A1 (fr) 1976-04-13 1976-04-13 Derives de la tetrahydro-1,2,3,3a indolo(3,2,1-de) (1,5)naphtyridine
FR7616445A FR2353550A2 (fr) 1976-06-01 1976-06-01 Procede de preparation de derives de naphtyridine
FR7632319A FR2368955A2 (fr) 1976-10-27 1976-10-27 Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine
FR7639035A FR2374905A2 (fr) 1976-12-24 1976-12-24 Derives de naphtyridine
FR7707249A FR2383182A2 (fr) 1977-03-11 1977-03-11 Nouveaux derives de naphtyridine
FR7707248A FR2383181A2 (fr) 1977-03-11 1977-03-11 Derives de naphtyridine

Publications (2)

Publication Number Publication Date
IL51853A0 IL51853A0 (en) 1977-06-30
IL51853A true IL51853A (en) 1979-11-30

Family

ID=27546337

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51853A IL51853A (en) 1976-04-13 1977-04-11 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US4190657A (es)
JP (1) JPS5823877B2 (es)
AR (1) AR214519A1 (es)
AU (1) AU506031B2 (es)
CA (1) CA1072960A (es)
CH (1) CH622795A5 (es)
DD (1) DD129791A5 (es)
DE (1) DE2716190A1 (es)
DK (1) DK143703C (es)
FI (1) FI63404C (es)
GB (1) GB1543283A (es)
GR (1) GR63658B (es)
IE (1) IE44989B1 (es)
IL (1) IL51853A (es)
LU (1) LU77100A1 (es)
MT (1) MTP811B (es)
MX (1) MX5340E (es)
NO (1) NO146777C (es)
NZ (1) NZ183846A (es)
PL (1) PL197373A1 (es)
PT (1) PT66428B (es)
SE (2) SE432932B (es)
SU (1) SU655314A3 (es)
YU (1) YU94877A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5337696A (en) * 1976-08-26 1978-04-06 Omnium Chimique Sa Hexahydrocantinonee6 derivative
US4228168A (en) * 1978-11-22 1980-10-14 Tanabe Seiyaku Co., Ltd. Azepino [1,2,3-lm]-β-carboline compounds and pharmaceutical composition thereof
US4367230A (en) * 1980-01-04 1983-01-04 Tanabe Seiyaku Co., Ltd. Novel triazafluoranthene compound and processes for preparing the same
FR2494693A1 (fr) * 1980-11-21 1982-05-28 Synthelabo Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique
FR2517679A1 (fr) * 1981-12-03 1983-06-10 Synthelabo Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique
LU84664A1 (fr) * 1983-02-25 1984-11-08 Onmichem S A Alkyl-4-indolonaphtyridines et leur application therapeutique
EP0347980A1 (en) * 1988-06-20 1989-12-27 Duphar International Research B.V 8,9-Annelated beta-carbolines and 8,9-anelated-3,4-dihydro-beta-carbolines
CN103193776A (zh) * 2013-04-16 2013-07-10 苏州维泰生物技术有限公司 一种具有抗肿瘤疗效的新型萘啶衍生物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299078A (en) * 1962-10-01 1967-01-17 Smith Kline French Lab Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
US3555018A (en) * 1968-12-03 1971-01-12 Ayerst Mckenna & Harrison Thiazinopyridoindolone derivatives

Also Published As

Publication number Publication date
NO146777C (no) 1982-12-08
SE8201181L (sv) 1982-05-25
SE432932B (sv) 1984-04-30
MTP811B (en) 1978-02-20
AU506031B2 (en) 1979-12-13
GB1543283A (en) 1979-04-04
YU94877A (en) 1983-01-21
DK143703B (da) 1981-09-28
CH622795A5 (es) 1981-04-30
DD129791A5 (de) 1978-02-08
PT66428B (fr) 1978-09-20
PL197373A1 (pl) 1978-02-13
SU655314A3 (ru) 1979-03-30
NO771263L (no) 1977-10-14
FI771159A (es) 1977-10-14
DE2716190A1 (de) 1977-10-27
SE7704172L (sv) 1977-10-14
IL51853A0 (en) 1977-06-30
FI63404C (fi) 1983-06-10
CA1072960A (en) 1980-03-04
AU2418977A (en) 1978-10-19
JPS52125198A (en) 1977-10-20
LU77100A1 (es) 1979-01-18
US4190657A (en) 1980-02-26
DK161377A (da) 1977-10-14
IE44989B1 (en) 1982-06-02
FI63404B (fi) 1983-02-28
NO146777B (no) 1982-08-30
DK143703C (da) 1982-04-13
JPS5823877B2 (ja) 1983-05-18
PT66428A (fr) 1977-05-01
GR63658B (en) 1979-11-28
NZ183846A (en) 1980-09-12
AR214519A1 (es) 1979-06-29
MX5340E (es) 1983-06-27
IE44989L (en) 1977-10-13

Similar Documents

Publication Publication Date Title
DE3065949D1 (en) Naphthyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3274351D1 (en) Camptothecin derivatives, processes for preparing same, formulations containing such derivatives and their use
IL62494A0 (en) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-one derivatives,their preparation and pharmaceutical compositions containing them
IL87809A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PH12259A (en) Substituted imidazo(1,2-a)pyridines and composition containing them
IL56078A (en) 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidin-4-one derivatives,their preparation and pharmaceutical compositions containing them
IL54815A (en) 5,11-dihydro-11-substitudet alkanoyl pyrido (2,3-b) (1,4) benzodiazepin-6-one derivatives their preparation and pharmaceutical compositions containing them
IL68442A0 (en) Imidazo(1,2-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL55338A0 (en) Novel pyrido (1,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
IL52997A0 (en) New 1h-pyrazolo(3,4-b)pyridine derivatives their preparation and pharmaceutical compositions containing them
IL50208A0 (en) Triazolo (3,4-b) isoquinoline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL54813A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing
IL58779A0 (en) 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carboxylates and their preparation
IL50930A (en) 1-alkyl-4-oxo-1,6,7,8-tetrahydro-4h-pyrido(1,2-a)pyrimidine-3-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
IL54814A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing tthem
IL61614A (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
IL50816A (en) 6-aryl-s-triazolo(4,3-a)-(or tetrazolo(1,5-a)pyrido(2,3-f)-diazepines, their preparation and pharmaceutical compositions containing them
IL51853A (en) 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL59802A0 (en) Substituted pyrido (1,2-a) pyrimidines,their preparation and pharmaceutical compositions containing them
PH12281A (en) 1,3,8-triazaspiro(4,5)decan-4-one derivatives and composition containing them
IL62295A0 (en) Pyrazolopyridine derivatives,their preparation and pharmaceutical compositions containing them
IL51092A0 (en) Naphthyridine derivatives and their preparation
IL46864A0 (en) New pyrimido(1,2-a)quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL54328A (en) Substituted pyrido(2,1-b)quinazoline-11-one derivatives,their manufacture and pharmaceutical compositions containing them